# Evaluation of Intravenous Ascorbic Acid

> **NCT01833351** · PHASE1 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 34 (actual)

## Conditions studied

- Safety and Pharmacokinetics of Intravenous Ascorbate

## Interventions

- **DRUG:** IV Vitamin C
- **DRUG:** IV Vitamin C

## Key facts

- **NCT ID:** NCT01833351
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2015-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01833351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01833351, "Evaluation of Intravenous Ascorbic Acid". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01833351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*